CASE REPORT article
Front. Med.
Sec. Gastroenterology
Volume 12 - 2025 | doi: 10.3389/fmed.2025.1688065
This article is part of the Research TopicExploring Adverse Drug Reactions: Monitoring, Mechanism, Intervention, and ResolutionView all 11 articles
A Case of Drug-Induced Pancreatitis Caused by Paroxetine with a Literature Review
Provisionally accepted
- Department of Emergency, Xi'an No 3 Hospital, Xi'an, China
Select one of your emails
You have multiple emails registered with Frontiers:
Notify me on publication
Please enter your email address:
If you already have an account, please login
You don't have a Frontiers account ? You can register here
Background: Acute pancreatitis (AP) incidence is ~76.2 per 100,000. Drug-induced pancreatitis (DIP) accounts for <2%, yet >500 drugs are implicated. Evidence linking the SSRI paroxetine to AP remains sparse. Case Presentation: A 28-year-old woman with severe depression self-initiated paroxetine 20 mg once daily; within 24 h she developed persistent epigastric pain and bloating. After brief relief with intravenous fluids she re-administered the same dose, and symptoms recurred within 24 h. Labs showed elevated pancreatic enzymes and CRP. CT revealed mild pancreatitis. No alcohol, hyperlipidemia or other classic risk factors were identified. Paroxetine was immediately discontinued; supportive care led to symptom and enzyme normalization within 72 h. She was discharged on trazodone and remains recurrence-free. Discussion: Population studies have not established a significant SSRI–AP association, probably because of the extreme rarity of such events (<0.01%). The positive rechallenge observed here provides robust individual-level evidence of causality, supported by formal probability scales and international criteria. SSRIs may precipitate AP through serotonin-mediated β-cell dysfunction, oxidative stress, or idiosyncratic hypersensitivity. Early recognition is critical because DIP is usually reversible after drug withdrawal. Conclusion: This case suggests that paroxetine may induce AP even at standard doses. Clinicians should consider DIP in patients lacking traditional risk factors, especially after self-rechallenge. Early recognition, immediate drug cessation and supportive therapy ensure excellent recovery.
Keywords: Paroxetine, acute pancreatitis, Drug-induced pancreatitis, Antidepressants, case report
Received: 18 Aug 2025; Accepted: 03 Oct 2025.
Copyright: © 2025 Wu, Lv, Liu and Liu. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence: YaDong Liu, lyd8758@126.com
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.